20 May 2021 - If you're looking for a story which encapsulates the duality of the pharmaceutical industry, you don't have to search much further than AbbVie.
That tale may finally be reaching a turning point, if bipartisan grilling of the company's CEO Richard Gonzalez by Congressional leaders on Tuesday are any indication.